CellOrigin Biotech

CellOrigin Biotech

CellOrigin Biotech and Qilu Pharmaceutical are co-developing allogeneic iPSC-derived chimeric antigen receptor macrophages (CAR-iMAC) to assist in the treatment of cancer.

Overview Structured Data Issues Contributors

en.cell-origin.com

Is a

Company attributes

Industry

Allogeneic cell therapy

Induced pluripotent stem cell

Stem-cell therapy

Location

Yuhang District

0

0

CEO

Founder

Pitchbook URL

pitchbook.com/profiles...470109-61

Legal Name

CellOrigin Technology (Hangzhou) Co., Ltd.

Email Address

info@cell-origin.com0

Phone Number

+17805815679

Full Address

21st Floor, Building 4, 1500 Wenyi West Road, Yuhang District, Hangzhou0

Investors

Jifeng Ventures

Yinxinggu Capital

Country

0

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like CellOrigin Biotech

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.